ViaGen Pets
ViaGen Pets is a Texas-based animal cloning and genetic preservation company that produces SCNT-based clones of dogs, cats, and horses for affluent owners and elite breeders, and partners with conservation institutions on endangered species cloning.
- Company typePrivate
- Founded2000
- HeadquartersCedar Park, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What ViaGen Pets does
ViaGen Pets is a privately held animal cloning and genetic preservation company operating in Cedar Park / Whitesboro, Texas with additional offices in Ocala, Florida and Lethbridge, Canada. The company uses somatic cell nuclear transfer (SCNT) — under an exclusive license to the Roslin Institute's patent portfolio that traces back to the Dolly the sheep technology — to produce genetically identical clones of dogs, cats, horses, and livestock, alongside cryopreservation and biobanking services. ViaGen reports an 80% cloning efficiency rate and a cumulative track record of over 2,000 animals cloned across 15 species, including more than 1,000 cloned foals and endangered species work such as Elizabeth Ann (the first cloned black-footed ferret) and the first cloned Przewalski's horse.
The company's revenue model is concentrated on high-value, one-time transactions: pet cloning at $50,000 per dog or cat, horse cloning at $85,000, and a $1,600 Genetic Preservation service that cryopreserves cells for future cloning, with recurring storage fees. Customers fall into three primary segments — affluent companion-animal owners served through a direct-to-consumer website, phone sales, and a 500+ veterinarian referral network; elite equine breeders purchasing cloning, ICSI, and sexed semen services; and conservation institutions including the San Diego Zoo Wildlife Alliance and the U.S. Fish and Wildlife Service for endangered-species work.
In November 2025, ViaGen was acquired by Colossal Biosciences, a Dallas-based de-extinction company valued at $10 billion, and now operates as a wholly owned subsidiary contributing reproductive services, cryopreservation, and cell banking to Colossal's broader conservation platform. The business has a 5-month waitlist on pet cloning, indicating demand exceeds current lab throughput.
ViaGen Pets firmographics
Firmographics- Name
- ViaGen Pets
- Legal name
- Viagen
- Website
- https://viagenpets.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ViaGen Pets is a Texas-based animal cloning and genetic preservation company that produces SCNT-based clones of dogs, cats, and horses for affluent owners and elite breeders, and partners with conservation institutions on endangered species cloning.
- Ownership category
- akta.pro rank
ViaGen Pets industry classification
Industry- Product category
- Animal Cloning Services
- NAICS
- Support Activities for Animal Production (1152)
- SIC
- Agricultural Services (700)
- akta.pro primary industry
- Companion/Specialty Animal Breeding & Genetics Services (non-livestock) (AFAEAJAO)
Keywords
Where ViaGen Pets is headquartered
LocationHeadquarters
- HQ city
- Cedar Park
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
ViaGen Pets business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pet Cloning Services: One-time high-value cloning services for dogs and cats at $50,000 each, paid in two equal installments. Revenue recognized upon successful delivery of cloned animals.
- Equine Cloning Services: Horse cloning at $85,000, paid in two equal installments. Targets elite performance horse owners and breeders preserving champion genetics.
- Genetic Preservation Services: $1,600 one-time fee for dog/cat genetic preservation including cell culture and cryopreservation. Optional recurring storage fees.
- Storage and Maintenance Fees: Ongoing storage fees for Genetic Preservation clients, including payments for storage fees through the online payment portal.
- ICSI and Sexed Semen Services: Additional equine reproductive services including ICSI and sexed semen processing, with separate contract pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Dog Cloning - $50,000 total |
| One time/ perpetual license | Multi-year contract | Cat Cloning - $50,000 total |
| One time/ perpetual license | Multi-year contract | Horse Cloning - $85,000 total |
| One time/ perpetual license | Pay-as-you-go | Genetic Preservation - $1,600 |
| Unit Pricing | Pay-as-you-go | Express Tissue Banking |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
ViaGen Pets product offering
Product offeringCore offering
ViaGen Pets is an animal biotechnology company that provides cloning and genetic preservation services for companion animals, performance horses, and endangered species. Core services include dog and cat cloning at $50,000, horse cloning at $85,000, genetic preservation cryopreservation at $1,600, and conservation cloning delivered through Somatic Cell Nuclear Transfer (SCNT) technology licensed from the Roslin Institute.
Product overview
ViaGen Pets is a pet and equine cloning company offering a comprehensive suite of genetic preservation and reproductive biotechnology services. The core offerings include pet cloning (dogs and cats at $50,000) and equine cloning ($85,000), supported by Genetic Preservation ($1,600) and Express Tissue Banking modules for long-term cell storage. Equine-specific services include ICSI and Sexed Semen sub-products. The company also maintains a Veterinary Network for biopsy support and partners with conservation organizations including the San Diego Zoo and U.S. Fish and Wildlife for endangered species preservation. ViaGen operates as a subsidiary of Colossal Biosciences following acquisition in November 2025.
Differentiator
Problem solved
Functional benefit
Products and services
- Pet Cloning Services Service enabling pet owners to create genetically identical clones of their dogs and cats using somatic cell nuclear transfer, priced at $50,000 per animal.
- Equine Cloning Services Horse cloning services that reproduce elite equine genetics, allowing owners to preserve champion bloodlines and performance genetics, priced at $85,000 per clone.
- Genetic Preservation (GP) Cryopreservation service that cultures and stores live cells from pet tissue samples, enabling future cloning options. Priced at $1,600 for dogs and cats.
- Express Tissue Banking (ETB) Lower-cost alternative to full genetic preservation that stores pet tissue samples without developing new cells, for potential future cloning use.
- ICSI (Intracytoplasmic Sperm Injection) Services Advanced equine fertility service involving injection of a single sperm cell into a mature oocyte, particularly beneficial for high-performance horses, older or lame mares, and limited semen situations.
- Sexed Semen Services Gender-sorted semen service providing greater than 95% accuracy when combined with ICSI, allowing equine breeders to select desired gender for breeding programs.
- Genetic Inventory & Semen Storage Semen storage and inventory management services for stallions, including stored semen and sexed semen options for use with ICSI programs.
- Conservation & Species Preservation Wildlife conservation cloning services partnering with institutions like San Diego Zoo Wildlife Alliance and U.S. Fish and Wildlife Service to preserve endangered species including black-footed ferret, Przewalski's horse, and other threatened animals.
Quantifiable outcome
- 80% cloning efficiency rate
- +4 more outcomes
Companies that use ViaGen Pets
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
ViaGen Pets technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
ViaGen Pets partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and key.
- Colossal BiosciencescoreColossal Biosciences acquired ViaGen Pets & Equine in November 2025, integrating reproductive services, cryopreservation, and cell banking into Colossal's conservation platform. ViaGen operates as a wholly owned subsidiary while continuing pet, equine, and livestock services. The acquisition strengthens Colossal's end-to-end toolkit spanning ancient DNA assembly, comparative genomics, genome engineering, and assisted reproduction.
- Roslin InstitutecoreExclusive licensee of the Roslin Institute's SCNT patent portfolio. Successfully commercialized somatic cell nuclear transfer for multiple species, including elite performance horses. The Roslin Institute is the organization that created Dolly the sheep.
- San Diego Zoo Wildlife AlliancecoreLong-standing partnership for conservation cloning. Contributed to first cloned black-footed ferret (Elizabeth Ann, born December 2020) and first cloned Przewalski's horse (born August 2020 from 1980 DNA). Active collaboration on BioVault initiatives.
- U.S. Fish and Wildlife ServicecorePartnership for black-footed ferret conservation program. Elizabeth Ann, the first cloned black-footed ferret, was produced in collaboration with USFWS to address severe genetic inbreeding in the reintroduced population of 400-500 individuals.
- Sexing TechnologieskeyPartnership for gender-sorted sperm services. Viagen works with Sexing Technologies to offer sex-sorted semen with greater than 95% accuracy when combined with ICSI program.
- Colossal FoundationcoreViagen works alongside the Colossal Foundation to bring advanced science to frontline conservation efforts. Partnership focuses on BioVault initiatives and scaling conservation cloning globally across 42+ biobanked species.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
ViaGen Pets competitors and assessment
Company assessmentEmerging players
- Revive & Restore: Conservation nonprofit advancing genetic rescue, biobanking, and cloning for endangered species. Closely adjacent to ViaGen's conservation/BioVault work and a collaborator in the wildlife cloning ecosystem.
- Embark Veterinary: Consumer dog DNA testing and breed identification company. Adjacent to ViaGen's pet genetic preservation business, focused on consumer genetic insights rather than reproductive cloning or cryopreservation.
- Wisdom Panel: Pet DNA testing service owned by Mars Petcare, offering breed identification and health screening. Operates in the consumer pet genetics space adjacent to ViaGen's genetic preservation offerings.
- Gemini Genetics: UK-based equine cloning and cryopreservation company offering horse cloning services comparable to ViaGen Equine. Directly competes in the elite equine cloning market, especially across European clients.
Broad incumbents
- Zoetis: Largest global animal health company offering genetics, reproductive pharmaceuticals, and breeding technologies. Operates in adjacent animal reproductive and genetic services rather than direct cloning competition.
Direct peers
- Sooam Biotech: South Korean biotech firm and the world's only other commercial-scale dog cloning provider, directly competing with ViaGen for global pet cloning customers using comparable SCNT technology.
- Sinogene: Beijing-based pet cloning company offering commercial dog and cat cloning services. Direct competitor to ViaGen in the global companion animal cloning market with similar Somatic Cell Nuclear Transfer capabilities.
Others
- Sexing Technologies: Animal genetics company specializing in sexed semen sorting. Existing ViaGen partner for equine sexed semen services, operating in the adjacent equine reproductive technology ecosystem.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ViaGen Pets social profiles
Digital presenceViaGen Pets financial estimates
Financial estimateRevenue estimate
Valuation estimate
ViaGen Pets leadership team
Management profileNumber of profiles
Profiles1 record
ViaGen Pets funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ViaGen Pets M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ViaGen Pets
What does ViaGen Pets do?
ViaGen Pets is an animal biotechnology company that provides cloning and genetic preservation services for companion animals, performance horses, and endangered species. Core services include dog and cat cloning at $50,000, horse cloning at $85,000, genetic preservation cryopreservation at $1,600, and conservation cloning delivered through Somatic Cell Nuclear Transfer (SCNT) technology licensed from the Roslin Institute.
Is ViaGen Pets a public or private company?
ViaGen Pets is a private company. It is classified as corporate owned and is currently operating.
When was ViaGen Pets founded?
ViaGen Pets was founded in 2000. It employs 11 to 50 people.
Where is ViaGen Pets based?
ViaGen Pets is headquartered in Cedar Park, United States, in the North America region.
How does ViaGen Pets make money?
Five revenue lines are on record. Pet Cloning Services are the primary driver. The others are equine Cloning Services, genetic Preservation Services, storage and Maintenance Fees and ICSI and Sexed Semen Services.
Who are ViaGen Pets's main competitors?
Emerging players on record are Revive & Restore, Embark Veterinary, Wisdom Panel and Gemini Genetics. Zoetis is listed as a broad incumbent. Direct peers are Sooam Biotech and Sinogene. Sexing Technologies is listed as an others.
Does ViaGen Pets have an API?
No public API is recorded for ViaGen Pets.
What industry is ViaGen Pets in?
ViaGen Pets's product category is Animal Cloning Services. Its primary akta.pro industry code is AFAEAJAO, Companion/Specialty Animal Breeding & Genetics Services (non-livestock). Its NAICS code is 1152 and its SIC code is 700.